{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:01:58Z","timestamp":1777428118100,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.intimp.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T10:01:42Z","timestamp":1397383302000},"page":"352-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase\/protease-activated receptor 2 interactions in hepatic stellate cells"],"prefix":"10.1016","volume":"20","author":[{"given":"Jing","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.04.001_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.mehy.2007.07.042","article-title":"A target role for mast cell in the prevention and therapy of hepatic fibrosis","volume":"70","author":"Shen","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.intimp.2014.04.001_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3748\/wjg.v11.i8.1141","article-title":"Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis","volume":"11","author":"Jeong","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.hepres.2005.01.007","article-title":"A role of mast cells for hepatic fibrosis in primary sclerosing cholangitis","volume":"31","author":"Ishii","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.intimp.2014.04.001_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-006-0305-3","article-title":"Mast cells in rheumatoid arthritis","volume":"26","author":"Maruotti","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vetimm.2010.05.005","article-title":"Phenotypical characterization, distribution and quantification of different mast cell subtypes in transmural biopsies from the gastrointestinal tract of cats with inflammatory bowel disease","volume":"137","author":"Kleinschmidt","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.0906-6705.2005.00315.x","article-title":"Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma","volume":"14","author":"Wang","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2559.2012.04197.x","article-title":"Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis","volume":"61","author":"Cha","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.intimp.2014.04.001_bb0050","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-006-9082-8","article-title":"The complex functions of mast cells in chronic human liver diseases","volume":"51","author":"Franceschini","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.intimp.2014.04.001_bb0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2044.2004.03757.x","article-title":"Mast cell tryptase: a review of its physiology and clinical significance","volume":"59","author":"Payne","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.intimp.2014.04.001_bb0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cellsig.2004.09.017","article-title":"The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1\/2)","volume":"17","author":"Frungieri","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.intimp.2014.04.001_bb0065","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1073\/pnas.232422999","article-title":"Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: possible relevance to human fibrotic disorders","volume":"99","author":"Frungieri","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2014.04.001_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1582-4934.2009.00980.x","article-title":"The coagulation factor Xa\/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm","volume":"14","author":"Borensztajn","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.intimp.2014.04.001_bb0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.1840080418","article-title":"Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver","volume":"8","author":"Fujiwara","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2014.04.001_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/dna.2013.2005","article-title":"Mast cells: a pivotal role in pulmonary fibrosis","volume":"32","author":"Veerappan","year":"2013","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s101570300005","article-title":"Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis","volume":"7","author":"Otsubo","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24784","article-title":"Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells","volume":"55","author":"Knight","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2014.04.001_bb0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/HYPERTENSIONAHA.111.169417","article-title":"Tryptase\/protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts","volume":"58","author":"McLarty","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2014.04.001_bb0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","article-title":"MiR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis","volume":"58","author":"Roderburg","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0110","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2014.04.001_bb0115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.1840080508","article-title":"Lipocytes and transitional cells in alcoholic liver disease: a morphometric study","volume":"8","author":"Mak","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2014.04.001_bb0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors","volume":"36","author":"Gaca","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2014.04.001_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2019.01.034","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:06:33Z","timestamp":1761584793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1567576914001222"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.04.001","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase\/protease-activated receptor 2 interactions in hepatic stellate cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}